| Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ... Nature 565 (7738), 234-239, 2019 | 1143 | 2019 |
| Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma MGM Roemer, RA Redd, FZ Cader, CJ Pak, S Abdelrahman, J Ouyang, ... Journal of Clinical Oncology 36 (10), 942, 2018 | 323 | 2018 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 266 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 248 | 2021 |
| Angiopoietin-2 as a biomarker and target for immune checkpoint therapy X Wu, A Giobbie-Hurder, X Liao, C Connelly, EM Connolly, J Li, ... Cancer immunology research 5 (1), 17-28, 2017 | 144 | 2017 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 32 | 2022 |
| Evaluating the PD-1 axis and immune effector cell infiltration in oropharyngeal squamous cell carcinoma JD Schoenfeld, E Gjini, SJ Rodig, RB Tishler, B Rawal, PJ Catalano, ... International Journal of Radiation Oncology* Biology* Physics 102 (1), 137-145, 2018 | 28 | 2018 |
| Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries JC Glasbey, TEF Abbott, A Ademuyiwa, A Adisa, E AlAmeer, S Alshryda, ... The Lancet 400 (10363), 1607-1617, 2022 | 27 | 2022 |
| Early years postgraduate surgical training programmes in the UK are failing to meet national quality standards: An analysis from the ASiT/BOTA Lost Tribe prospective cohort … JC Glasbey, RL Harries, AJ Beamish, VJ Gokani, H Mohan, AP Williams, ... International Journal of Surgery 52, 376-382, 2018 | 19 | 2018 |
| Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study TCIR Network, COVIDSurg Collaborative The Journal of thoracic and cardiovascular surgery 162 (2), e355, 2021 | 11 | 2021 |
| Expression of major histocompatibility complex (MHC) class II, but not MHC class I, predicts outcome in patients with classical Hodgkin lymphoma (cHL) treated with nivolumab … MGM Roemer, RA Redd, FZ Cader, CJ Pak, S Abdelrahman, J Ouyang, ... Blood 130, 1450, 2017 | 3 | 2017 |
| The tumor suppressor effect of miRNA 200-c-3p on A549 non-small cell lung cancer cell line is associated with down-regulation of programmed cell death ligand 1; an immune-check … S Ezzat, MI Mohamad, MB Ahmed, SE Abdelrahman, N El-Khazragy, ... Cellular and Molecular Biology 70 (3), 13-21, 2024 | | 2024 |
| 1013 Preoperative Nasopharyngeal Swab Testing and Postoperative Pulmonary Complications in Patients Undergoing Elective Surgery During The SARS-Cov-2 Pandemic COVIDSurg Collaborative British Journal of Surgery 108 (Supplement_2), znab135. 039, 2021 | | 2021 |
| Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection S Tabiri, SK Kamarajah, D Nepogodiev, E Li, J Simoes, S Sravanam, ... Bjs Open, 2021 | | 2021 |
| Intratumoral T cell response detected after personal neoantigen vaccine in a phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, N Mathewson, S Li, G Oliveira, ... Nature, 2020 | | 2020 |
| The tumor-immune microenvironment (TME) in HR+/HER2-metastatic breast cancer (mBC): Relationship to non-metastatic (met) tumors and prior treatment (tx) received. AG Waks, SM Tolaney, SJ Schnitt, D Dillon, E Gjini, S Abdelrahman, ... Journal of Clinical Oncology 36 (15_suppl), 1054-1054, 2018 | | 2018 |
| Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin Lymphoma R GMM, R RA, C FZ, P CJ, S Abdelrahman, J Ouyang, S Sasse, A Younes, ... | | 2018 |
